AbbVie (ABBV) Files for Skyrizi to Treat Crohn's Disease in EU

AbbVie (ABBV) submits a regulatory application in the European Union, seeking approval for risankizumab (Skyrizi) for the treatment of Crohn's disease.

from Entrepreneur: Latest Articles AbbVie (ABBV) submits a regulatory application in the European Union, seeking approval for risankizumab (Skyrizi) for the treatment of Crohn's disease. https://ift.tt/eA8V8J December 01, 2021 at 09:52PMhttps://https://ift.tt/2ZJPm9D

Post a Comment

0 Comments